Join the fight to fund cancer research

September 17, 2014 | by

Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before.

City of Hope supports the Rally for Medical Research on Capitol Hill this week, which urges lawmakers to make funding medical research a high priority.

City of Hope supports the Rally for Medical Research on Capitol Hill this week, which urges lawmakers to make funding medical research a high priority.

The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital and laboratory, there is another front for the fight against cancer: The battle for funding to keep this research ongoing.

City of Hope joins the American Association for Cancer Research in support of the Rally for Medical Research on Capitol Hill on Thursday, Sept. 18. Hundreds of organizations and individuals – comprehensive cancer centers, research advocacy groups, clinicians, business leaders, survivors and others – are joining the call to members of Congress to make funding for the National Institutes of Health a priority and stop the chronic decline of public funding for science.
» Continue Reading

AACR report: Now is the time to invest in cancer research

September 16, 2014 | by

Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life.

Scientist in laboratory

With new drugs approved and new scientific breakthroughs, the chances of surviving cancer have never been higher. Now is the time to keep investing in cancer research.

However, much work remains to be done. On average, one American will die of cancer every minute of every day this year, according to the American Association for Cancer Research, which today released its annual Cancer Progress Report.  Following a year that saw six new cancer drugs approved, an estimated 14.5 million cancer survivors living in the United States, and considerable research breakthroughs, now is the time to continue fueling lifesaving cancer research through investment in the National Institutes of Health, National Cancer Institute and other organizations and agencies devoted to cancer research.

While gains in cancer research have been impressive, the pace of progress has been slowed due to years of budget cuts at the NIH and NCI.

“Incredible strides have been made in advancing our understanding, enhancing prevention and improving therapy of cancer,” said Steven Rosen, M.D., provost and chief scientific officer at City of Hope and director of the Comprehensive Cancer Center. “To maintain momentum with the ultimate goal of maximizing cure of these devastating diseases, the necessary funds must be available.”

» Continue Reading

More children are being diagnosed with kidney cancer and thyroid cancer

September 12, 2014 | by

Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children.

thyroid cancer in children

The rates of kidney cancer and thyroid cancer are increasing in children and adolescents, according to a new study published in the October issue of Pediatrics.

The study, published online this month in Pediatrics, examined childhood cancer incidence rates from 2001 to 2009 and found an annual increase of nearly 5 percent for thyroid cancer and a 5.4 increase for renal carcinoma, the most common type of kidney cancer.

Researchers also found that there was a 1.3 percent increase in the overall cancer trend among African-American children and adolescents.

Raynald Samoa, M.D., assistant professor in the Department of Clinical Diabetes, Endocrinology & Metabolism at City of Hope, told CBS News that the rise in pediatric patients with thyroid cancer is undeniable. “We’ve seen a dramatic increase,” said Samoa. “I think we’ve seen almost a [doubling] of referrals over past several years.”

» Continue Reading

Teens, young adults with brain cancer need comprehensive cancer centers

September 10, 2014 | by

Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why.

Teens with brain cancer have better outcomes at NCI-designated cancer centers.

Older adolescents and young adults with brain and spinal cord tumors have better outcomes when treated at National Cancer Institute-designated comprehensive cancer centers, research finds.

A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examined the cancer registry, looking at the entire Los Angeles County population of older adolescents and young adults — collectively known as AYAs — and children diagnosed with central nervous system (CNS) cancers, which include tumors of the brain and spinal cord.

The study included nearly 1,350 patients: children 14 years old and under and AYAs, who fall between the ages of 15 and 39. The National Cancer Institute (NCI) has determined that AYA patients form a special group because of unique challenges they face in cancer treatment, and this study was the first to assess the impact on survival of where an AYA patient receives care.

The scientists, led by Julie Wolfson, M.D., M.S.H.S., assistant professor, and Smita Bhatia, M.D., M.P.H., the Ruth Ziegler Chair in Population Sciences, found that both children and AYAs with a select group of CNS tumors who were treated at NCI-designated comprehensive cancer centers such as City of Hope fared better than those seeking care at adult community facilities. In some cases, the difference in five-year survival rates was more than 10 percent. Of special note, the AYAs with these cancers fared worse than the children, but by receiving care at an NCI-designated comprehensive cancer center, this difference was wiped away.

» Continue Reading

Diet during cancer treatment: Tips to ease dry mouth

September 8, 2014 | by

Cancer treatment can take a toll on the mouth, even if a patient’s cancer has nothing to do with the head or throat, leading to a dry mouth, or a very sore mouth, and making it difficult to swallow or eat.

Here’s some advice from the National Cancer Institute (NCI)  on how to ease cancer-related discomfort of the mouth.

cancer treatment side effects

Popsicles can help cancer patients ease the dry mouth caused by some cancer treatments.

Dry mouth

Chemotherapy and radiation to the upper body can damage the salivary glands, reducing the production of saliva and making it harder to talk, chew and swallow food. Some medications can also be cause dry mouth. Try these tips to alleviate dry mouth: » Continue Reading

7 tips for managing cancer pain: First, control it early

September 4, 2014 | by

There’s more to cancer care than simply helping patients survive. There’s more to cancer treatment than simple survival.

pain illustration

Cancer patients should report their pain to their caregivers, and enlist their doctors to help them manage it. Pain does not have to be part of daily life, even during cancer treatment, says City of Hope’s Betty Ferrell and other experts in palliative care.

Constant pain should not be part of conquering cancer,  insists Betty Ferrell, Ph.D., R.N., director of nursing research and education at City of Hope. She wants patients and caregivers alike to understand, and act on, this principle.

Ferrell, an international expert in palliative care, and her colleagues have spent years investigating pain management and the barriers that prevent patients from receiving the help and medication needed to manage their pain. Overcoming these barriers starts with understanding that pain management is vital. Even when people are fighting cancer, their day-to-day lives should not hampered by physical pain.

“Patients and caregivers need to understand that pain is important,” she said. “Pain has a tremendous impact on quality of life. There is an urgency. If pain is not controlled, their lives are out of control.”

» Continue Reading

Bone marrow transplant may be answer to incurable, fatal blood disease

September 4, 2014 | by

Even its name is daunting. Systemic mastocytosis is a fatal disease of the blood with no known cure. But a new study suggests a bone marrow transplant may be the answer for some patients.

Nakamura and Pullarkat

Systemic mastocytosis is currently considered a fatal blood disorder. City of Hope researchers Ryotaro Nakamura, left, and Vinod Pullarkat have found that bone marrow transplantation could offer a cure.

While rare, systemic mastocytosis is resistant to treatment with drugs and, when aggressive, can be fatal within four years of diagnosis. No standard therapy currently exists for the disease, which is caused by an overabundance of mast cells in the blood and bone marrow.

Mast cells are a type of white blood cell that normally helps in wound healing and in defending against infectious disease agents. The cells also are involved in allergic reactions including anaphylaxis, a severe reaction that can sometimes lead to death.

Patients with mastocytosis tend to develop hives and itching and are prone to anaphylactic shock. They also can develop other blood cancers such as leukemia and myelodysplasia together with systemic mastocytosis. » Continue Reading

High-fat diet? You are what you eat, right down to your DNA

September 3, 2014 | by

Could what you eat affect the health of your chromosomes? The short answer is, “Yes.”

Rama Natarajan and Dustin Schones

A high-fat diet may lead to detrimental changes to your chromosomes say Rama Natarajan, left, and Dustin Schones.

Researchers led by Dustin Schones, Ph.D., assistant professor in the Department of Cancer Biology, and Rama Natarajan, Ph.D., director of the Division of Molecular Diabetes Research and the National Business Products Industry Professor in Diabetes Research, have found that a high-fat diet can lead to chemical changes in chromatin, the bundles of DNA and protein that form chromosomes. Further, the team found that those changes to chromatin structure can, in fact, alter the way genes are expressed in cells.

Researchers have long known that diet is a key factor leading to metabolic diseases such as type 2 diabetes. These disorders result in abnormal processing of fats, proteins, sugars and other important molecules in the body.

» Continue Reading

Cancer insights: Urologist Bertram Yuh on prostate cancer risk

September 2, 2014 | by

September is Prostate Cancer Awareness Month. Here, Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, explains the importance of understanding the risk factors for the disease and ways to reduce those risks, as well as overall prostate health.

Prostate cancer expert Bertram Yuh

Bertram Yuh, a urologic cancer expert at City of Hope, explains prostate cancer risk factors and how to reduce them.

“What are my prostate cancer risks?” That’s becoming a more common, and increasingly important, question.

A lot of men wonder what can be done to prevent or reduce their risk of prostate cancer. The good news is, there’s a lot of research being conducted in this area regarding risks and influencing factors.

We already know there are racial predilections, such as that African-American men are more likely to get prostate cancer and that, when they’re diagnosed, the cancer tends to be more aggressive. We also know that prostate cancer is less common in Asian-American and Hispanic men.

Further, while prostate cancer is certainly more common in older men, there is some recent clinical literature that states prostate cancer in younger men can be more aggressive. It is quite possible for a 47-year-old and a 77-year-old to have prostate cancers that behave differently.

I can’t treat every patient the same way just because their prostate-specific antigen (PSA) or Gleason grades look the same. In my role as a urology oncologist, I need to look at the whole patient.

» Continue Reading

Prostate cancer infographic: How to reduce prostate cancer risk

September 1, 2014 | by

Prostate Health**
Learn more about prostate health, plus prostate cancer research and treatment, at City of Hope.


Learn more about getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and help you determine, before you come in, whether or not your insurance will pay for the appointment.